| ADR Ontology |
| ADR Term |
Blood lactate dehydrogenase increased |
| ADR ID |
BADD_A00573 |
| ADR Hierarchy |
|
| Description |
A finding based on laboratory test results that indicate increased levels of lactate dehydrogenase in the blood specimen. [CTCAE] |
| MedDRA Code |
10005630 |
| MeSH ID |
Not Available
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Blood lactate dehydrogenase increased | Dehydrogenase lactic blood urine increased | Lactate dehydrogenase increased | Lactic dehydrogenase activity inc | Lactic dehydrogenase activity increased | Lactic dehydrogenase increased | LDH blood urine increased | LDH inc | LDH increased | LDH increased serum | Plasma lactic dehydrogenase increased | Serum lactic dehydrogenase increased | Serum LDH raised | Blood lactate dehydrogenase high | Blood lactate dehydrogenase 1 increased | Blood lactate dehydrogenase 2 increased | Blood lactate dehydrogenase 3 increased | Blood lactate dehydrogenase 4 increased | Blood lactate dehydrogenase 5 increased |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02480 | Alectinib | 0.000533% | | | BADD_D02505 | Gilteritinib | 0.000533% | |
| The 9th Page First
Pre
9
Total 9 Pages
|
|
